Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru.
BACKGROUND:Nearly half of the world's population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection...
Main Authors: | Brett M Forshey, Robert C Reiner, Sandra Olkowski, Amy C Morrison, Angelica Espinoza, Kanya C Long, Stalin Vilcarromero, Wilma Casanova, Helen J Wearing, Eric S Halsey, Tadeusz J Kochel, Thomas W Scott, Steven T Stoddard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4746126?pdf=render |
Similar Items
-
Long-term and seasonal dynamics of dengue in Iquitos, Peru.
by: Steven T Stoddard, et al.
Published: (2014-07-01) -
Dengue Virus Serotype 4, Northeastern Peru, 2008
by: Brett M. Forshey, et al.
Published: (2009-11-01) -
Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission.
by: Amy C Morrison, et al.
Published: (2010-05-01) -
Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples.
by: Subhamoy Pal, et al.
Published: (2014-01-01) -
The impact of insecticide treated curtains on dengue virus transmission: A cluster randomized trial in Iquitos, Peru.
by: Audrey Lenhart, et al.
Published: (2020-04-01)